• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[欧共体国家药品的分销结构]

[The structure of distribution of pharmaceutical products in the countries of the EEC].

作者信息

Passerini F

机构信息

Teknibank SpA-Corso Italia, Milano.

出版信息

Boll Chim Farm. 1990 May;129(5):199-209.

PMID:2083056
Abstract

The aim of the study is to focus on the basic aspects of the distribution structure in the pharmaceutical industry of the EEC countries. The unique features of the pharmaceutical business, which make it different from all other industrial areas are pointed out with an analytical approach. The industry examination performed and the comparison between the structures existing in each country, have given the opportunity to underline certain typical behaviours of the pharmaceutical industries within the 1992 European scenario.

摘要

该研究的目的是聚焦于欧共体国家制药行业分销结构的基本方面。采用分析方法指出了制药行业有别于所有其他工业领域的独特特征。所进行的行业考察以及各国现有结构之间的比较,使得我们有机会突出1992年欧洲形势下制药行业的某些典型行为。

相似文献

1
[The structure of distribution of pharmaceutical products in the countries of the EEC].[欧共体国家药品的分销结构]
Boll Chim Farm. 1990 May;129(5):199-209.
2
Future European health care: cost containment, health care reform and scientific progress in drug research.未来的欧洲医疗保健:成本控制、医疗改革与药物研究的科学进展。
Int J Health Plann Manage. 1997 Apr-Jun;12(2):81-101. doi: 10.1002/(SICI)1099-1751(199704)12:2<81::AID-HPM460>3.0.CO;2-3.
3
European prices of newly launched reimbursable pharmaceuticals--a pilot study.新上市可报销药品的欧洲价格——一项试点研究。
Health Policy. 2005 Nov;74(3):235-46. doi: 10.1016/j.healthpol.2005.01.005.
4
Pharmaceutical price differences in the EU: investigation from cardiovascular disease drugs.
Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):251-6. doi: 10.1586/erp.09.24.
5
Issues with regulatory pharmacovigilance in East European countries: the industry perspective.东欧国家药品监管中的药物警戒问题:行业视角
Toxicol Lett. 2007 Feb 5;168(3):228-35. doi: 10.1016/j.toxlet.2006.10.019. Epub 2006 Nov 16.
6
[The European Union and drugs].[欧盟与毒品]
Ann Pharm Fr. 1995;53(4):184-7.
7
[Coordination of industrial research of foodstuffs in the countries of the EEC and in other European countries associated with the EEC within the framework of COST].[在欧洲科学技术合作组织框架内,欧洲经济共同体国家与其他与欧洲经济共同体相关的欧洲国家之间食品工业研究的协调]
Ann Nutr Aliment. 1978;32(2-3):689-97.
8
[How the EEC membership influences drug supply in Sweden].
Lakartidningen. 1995 Feb 8;92(6):491-3.
9
[An interview with Dr. D. Poggiolini, director of the Pharmaceutical Service of the Health Ministry and the Drug Committee of the EEC. Interview by Giuseppe Lojacono].
Epidemiol Prev. 1988 Dec;10(37):9.
10
[Guiding principles for industrial policy in the pharmaceutical sector of the European Community. European Economic Community].
Boll Chim Farm. 1996 Nov;135(10):575-9.